A clinical study of Digestive Health Capsules in the management of Grahani Roga with special reference to Irritable Bowel Syndrome

Rohini Jat; Preeti Gavali; Pawankumar Godatwar; Harshad Jain; Neeraj Kumar Patel; Jahan Peston Jamas

doi:10.21760/jaims.9.4.3

Rohini Jat Post Graduate Scholar, Department of Roga Nidana evam Vikriti Vigyana, National institute of Ayurveda (De Novo), Jaipur, Rajasthan, India.
Preeti Gavali Assistant Professor, Department of Roga Nidana evam Vikriti Vigyana, National institute of Ayurveda (De Novo), Jaipur, Rajasthan, India.
Pawankumar Godatwar Technical officer, SEARO WHO, New Delhi, India.
Harshad Jain Ayurvedic Medical Practitioner, Bombay Hemp Company Pvt. Ltd., Mumbai, Maharashtra, India.
Neeraj Kumar Patel Head of Research & Development, Bombay Hemp Company Pvt. Ltd., Mumbai, Maharashtra, India.
Jahan Peston Jamas Chief Strategy Officer, Bombay Hemp Company Pvt. Ltd., Mumbai, Maharashtra, India.

DOI: https://doi.org/10.21760/jaims.9.4.3

Keywords: Grahani Roga, Digestive Health Capsules, Irritable Bowel Syndrome, Quality of Life

Abstract

Background: Clinical manifestation of Grahani Roga is similar to irritable bowel syndrome (IBS). IBS is not a life-threatening condition but it can significantly impact the quality of life. The prevalence of IBS varies from 12% to 15% in India. It is 3 times more common in women and people of working age. Due to the wide spectrum of disease, much prevalence in society and lack of effective medicines, the disease has been chosen for the trial. Digestive Health Capsules manufactured by Bombay Hemp Company is used in patients suffering from Grahani Roga (IBS). Aim: The aim of this study was to study the safety and efficacy of Digestive Health Capsules in the management of Grahani Roga (IBS). Materials and Methods: Forty clinically diagnosed patients of Grahani Roga (IBS) were selected and administered Digestive Health Capsules - 1 capsule twice a day with water after meal for 8 weeks. Study Design: It was an open labeled, single center, single arm clinical study. Results: The result was highly significant for all the subjective and objective parameters. Conclusion: Digestive Health Capsules can be used as safe and effective drug of choice in patients suffering from Grahani Roga (Irritable Bowel Syndrome).

Downloads

Download data is not yet available.

References

Irritable bowel syndrome. Ford AC, Lacy BE, Talley NJ. N Engl J Med. 2017; 376:2566-2578. [PubMed] [Google Scholar]

Review article: the economic impact of the irritable bowel syndrome. Canavan C, West J, Card T. Aliment Pharmacol Ther. 2014; 40:1023-1034. [PubMed] [Google Scholar]

The effect of irritable bowel syndrome on health related quality of life and health care expenditures. Agarwal N, Spiegel BM. Gastroenterol Clin North Am. 2011;40:11-19. [PubMed] [Google Scholar]

Irritable bowel syndrome: a clinical review. Chey WD, Kurlander J, Eswaran S. JAMA. 2015; 313:949-958. [PubMed] [Google Scholar]

Irritable bowel syndrome: epidemiology, pathophysiology, diagnosis and treatment. Defrees DN, Bailey J. Prim Care. 2017; 44:655-671. [PubMed] [Google Scholar]

Agnivesha, Charaka, Dridhabala, Charaka Samhita, Sutra Sthana, Ashtodariya Adhyaya 19/7, edited by Yadavji Trikamji Acharya, reprint edition, Chaukhamba Surbharti Publication, Varanasi, 2001;112.

Masand PS, Keuthen NJ, Gupta S, Virk S, YuSiao B, Kaplan D. Prevalence of irritable bowel syndrome in obsessivecompulsive disorder. CNS Spectr 2006; 11:215.

Agnivesha, Charaka, Dridhabala, Charaka Samhita, Chikitsa Sthana, Atisara Chikitsa Adhyaya, 19, edited by Yadavji Trikamji Acharya, reprint edition, Chaukhamba Surbharti Publication, Varanasi, 2001;547.

Agnivesha, Charaka, Dridhabala, Charaka Samhita, Chikitsa Sthana Grahnichikitsa Adhyaya, 15, edited by Yadavji Trikamji Acharya, reprint edition, Chaukhamba Surbharti Publication, Varanasi, 2001;511.

Agnivesha, Charaka, Dridhabala, Charaka Samhita, Vimana Sthana Trividhakukshiya Adhyaya 2/3, edited by Yadavji Trikamji Acharya, reprint edition, Chaukhamba Surbharti Publication, Varanasi, 2001;252.

Occhipinti K, Smith JW. Irritable bowel syndrome: a review and update. Clin Colon Rectal Surg 2012; 25: 46-52 [PMID: 23449495 DOI: 10.1055/s-0032-1301759]

Charaka Samhita. Chakrapanidatta. Sharma RK, Bhagawandash, editors. Chikitsa Sthana. Varanasi: Chowkhamba Sanskrita Series; 2001. p. 73.

Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997; 11:395402.

Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Phamacol Ther. 1997; 11:395-402. [PubMed] [Google Scholar]

Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci. 1998; 43:400-411. [PubMed] [Google Scholar]

Kavitha D, Shilpa PN, Devaraj SN. Antibacterial and antidiarrhoeal effects of alkaloids of Holarrhena antidysenterica WALL. Indian J Exp Biol 2004; 42:58994.

Parmar N, Patel BR, Patil B. A review on classical therapeutic uses of Bilva (Aegle marmelos corr.) Pharma Sci Monitor 2014;5: 21-30.